Providers Recommending Obesity Pharmacotherapy For Tweens

Providers Recommending Obesity Pharmacotherapy For Tweens

In 2023, more than 1,200 kids between the ages of 12 and 17 were prescribed semaglutide for obesity, according to an analysis of insurance claims by Komodo Health. Additionally, when data from Medicaid programs in 5 selected states was analyzed by Reuters, more than 460 children were found to be taking the weight management drug. The bottom line seems to indicate that providers are embracing obesity pharmacotherapy for tweens. Of note, it was December 2022 …

Read More

Abstracts in Urgent Care – April 2018

ACP Eases Up on A1c Ceiling for Patients with Type 2 Diabetes Key point: The American College of Physicians suggests slightly higher hemoglobin A1c target levels for patients with type 2 diabetes. Citation: Qaseem A, Wilt TJ, Kansagara D, et al. Hemoglobin A1C targets for glycemic control with pharmacologic therapy for nonpregnant adults with type 2 diabetes mellitus: a guidance statement update from the American College of Physicians. Ann Intern Med. March 6, 2018. [Epub ahead …

Read More